Literature DB >> 32651888

Development of phage delivery by bioencapsulation of artemia nauplii with Edwardsiella tarda phage (ETP-1).

Chamilani Nikapitiya1, S H S Dananjaya1, Shan Lakmal Edirisinghe1, H P S U Chandrarathna1, Jehee Lee2,3, Mahanama De Zoysa4.   

Abstract

This study proposed that phage-enriched artemia could be a useful tool for transferring phage into the cultured fish (larvae or adult) as a feed, and introduce mode of phage administration and its safety in concern of tissue adaptation for efficient phage therapy in aquatic animals. First, whether Edwardsiella tarda phage (ETP-1) could attach or ingest by the artemia and optimum time period for the ETP-1 enrichment with artemia were investigated. ETP-1 dispersion, abundance and persistency, and zebrafish immune transcriptional responses and histopathology were evaluated after feeding the fish with ETP-1-enriched artemia. Hatched artemia nauplii (36 h) were enriched with 1.90 × 1011 PFUmL-1 of ETP-1, and maintained at 25 °C. The highest enrichment level was obtained after 4 h (3.00 × 109 PFUmL-1), and artemia were alive and active similar to control for 8 h. ETP-1 disseminated dose dependently to all the tissues rapidly (12 h). However, when feeding discontinued, it drastically decreased at day 3 with high abundance and persistency in the spleen (1.02 × 103) followed by the kidney (4.00 × 101) and the gut (1 × 101 PFUmL-1) for highest ETP-1-enriched artemia dose. In contrast, during continuous delivery of ETP-1-enriched artemia, ETP-1 detected in all the tissues (at day 10: gut; 1.90 × 107, kidney; 3.33 × 106, spleen; 5.52 × 105, liver; 6.20 × 104 PFUmL-1mg-1 tissues). Though the phage abundance varied, results indicated that oral fed ETP-1-enriched artemia disperse to the neighboring organs, even the absence of host as phage carrier. Non-significant differences of immune transcriptional and histopathology analysis between ETP-1-enriched artemia fed and controls suggest that no adverse apparent immune stimulation in host occurred, and use of ETP-1 at 1011 PFUmL-1 was safe. With further supportive studies, live artemia-mediated phage delivery method could be used as a promising tool during phage therapy against pathogenic bacteria to control aquatic diseases.

Entities:  

Keywords:  Artemia sp.; Brine shrimp nauplii; ETP-1 phage; Edwardsiella tarda; Phage delivery; Phage therapy; Zebrafish

Year:  2020        PMID: 32651888      PMCID: PMC7688814          DOI: 10.1007/s42770-020-00324-y

Source DB:  PubMed          Journal:  Braz J Microbiol        ISSN: 1517-8382            Impact factor:   2.476


  19 in total

Review 1.  Bacteriophage therapy of infectious diseases in aquaculture.

Authors:  Toshihiro Nakai; Se Chang Park
Journal:  Res Microbiol       Date:  2002 Jan-Feb       Impact factor: 3.992

Review 2.  Antimicrobial resistance in aquaculture: Current knowledge and alternatives to tackle the problem.

Authors:  Lúcia Santos; Fernando Ramos
Journal:  Int J Antimicrob Agents       Date:  2018-03-19       Impact factor: 5.283

3.  Dispersal and survival of Flavobacterium psychrophilum phages in vivo in rainbow trout and in vitro under laboratory conditions: implications for their use in phage therapy.

Authors:  Lone Madsen; Sif K Bertelsen; Inger Dalsgaard; Mathias Middelboe
Journal:  Appl Environ Microbiol       Date:  2013-06-07       Impact factor: 4.792

4.  Treatment of vibriosis in European sea bass larvae, Dicentrarchus labrax L., with oxolinic acid administered by bath or through medicated nauplii of Artemia franciscana (Kellogg): efficacy and residual kinetics.

Authors:  M Touraki; I Niopas; V Karagiannis
Journal:  J Fish Dis       Date:  2012-06-06       Impact factor: 2.767

5.  Isolation and identification of bacteriophages infecting ayu Plecoglossus altivelis altivelis specific Flavobacterium psychrophilum.

Authors:  Ji Hyung Kim; Dennis K Gomez; Toshihiro Nakai; Se Chang Park
Journal:  Vet Microbiol       Date:  2009-07-09       Impact factor: 3.293

6.  Isolation and characterization of phage (ETP-1) specific to multidrug resistant pathogenic Edwardsiella tarda and its in vivo biocontrol efficacy in zebrafish (Danio rerio).

Authors:  Chamilani Nikapitiya; H P S U Chandrarathna; S H S Dananjaya; Mahanama De Zoysa; Jehee Lee
Journal:  Biologicals       Date:  2019-12-27       Impact factor: 1.856

Review 7.  Bacteriophages: Protagonists of a Post-Antibiotic Era.

Authors:  Pilar Domingo-Calap; Jennifer Delgado-Martínez
Journal:  Antibiotics (Basel)       Date:  2018-07-27

Review 8.  Pathogenesis of and strategies for preventing Edwardsiella tarda infection in fish.

Authors:  Seong Bin Park; Takashi Aoki; Tae Sung Jung
Journal:  Vet Res       Date:  2012-10-04       Impact factor: 3.683

9.  Characterization of antibiotic resistance in commensal bacteria from an aquaculture ecosystem.

Authors:  Ying Huang; Lu Zhang; Laura Tiu; Hua H Wang
Journal:  Front Microbiol       Date:  2015-09-08       Impact factor: 5.640

10.  T4 phage and its head surface proteins do not stimulate inflammatory mediator production.

Authors:  Paulina Miernikiewicz; Krystyna Dąbrowska; Agnieszka Piotrowicz; Barbara Owczarek; Justyna Wojas-Turek; Jagoda Kicielińska; Joanna Rossowska; Elżbieta Pajtasz-Piasecka; Katarzyna Hodyra; Katarzyna Macegoniuk; Kamila Rzewucka; Agnieszka Kopciuch; Tomasz Majka; Andrey Letarov; Eugene Kulikov; Henryk Maciejewski; Andrzej Górski
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240

View more
  2 in total

Review 1.  Bacteriophage therapy in aquaculture: current status and future challenges.

Authors:  Ruyin Liu; Ganghua Han; Zong Li; Shujuan Cun; Bin Hao; Jianping Zhang; Xinchun Liu
Journal:  Folia Microbiol (Praha)       Date:  2022-03-19       Impact factor: 2.629

2.  Bacteriophage Encapsulation in pH-Responsive Core-Shell Capsules as an Animal Feed Additive.

Authors:  Kerry Richards; Danish J Malik
Journal:  Viruses       Date:  2021-06-11       Impact factor: 5.048

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.